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Abstract 
Focused ultrasound (FUS) exposure in the presence of microbubbles (MBs) has been 
successfully used in the delivery of various sizes of therapeutic molecules across the 
blood-brain barrier (BBB). While acoustic pressure is correlated with the BBB opening 
size, real-time control of BBB opening to avoid vascular and neural damage is still a 
challenge. This arises mainly from the variability of FUS-MB interactions due to the 
variations of animal-specific metabolic environment and specific experimental setup. 
In this study, we demonstrate a closed-loop cavitation control framework to induce BBB 
opening for delivering large therapeutic molecules without causing macro tissue 
damages. To this end, we performed in mice long-term (5 min) cavitation monitoring 
facilitated by using long-circulating MBs. Monitoring the long-term temporal kinetics of 
the MBs under varying level of FUS pressure allowed to identify in-situ, animal specific 
activity regimes forming a pressure-dependent activity bands. This enables to 
determine the boundaries of each activity band (i.e. steady oscillation, transition, 
inertial cavitation) independent from the physical and physiological dynamics of the 
experiment. However, such a calibration approach is time consuming and to speed up 
characterization of the in-situ, animal specific FUS-MB dynamics, we tested a novel 
method called “pre-calibration” that closely reproduces the results of long-term 
monitoring but with a much shorter duration. Once the activity bands are determined 
from the pre-calibration method, an operation band can be selected around the desired 
cavitation dose. To drive cavitation in the selected operation band, we developed an 
adaptive, closed-loop controller that updates the acoustic pressure between each 
sonication based on measured cavitation dose. Finally, we quantitatively assessed the 
safety of different activity bands and validated the proposed methods and controller 
framework. The proposed framework serves to optimize the FUS pressure instantly to 
maintain the targeted cavitation level while improving safety control.   
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Introduction 
Focused ultrasound (FUS) in combination with intravenously administered 
microbubbles (MBs) is a unique method to open the blood-brain barrier (BBB) locally, 
transiently and noninvasively (Hynynen et al., 2001; McDannold et al., 2005) . Using 
this technique, a variety of drugs with different sizes has been delivered to the brain 
parenchyma such as small anti-cancer chemotherapeutics (MW  < 1000 Da)(Treat et 
al., 2012), neurotrophins (MW  ̴20 kDa) (Baseri et al., 2012), large amyloid β antibodies 
(MW 1̴50 kDa) (Jordao et al., 2013) and other therapeutic macromolecules for 
treatment of glioblastoma (Liu et al., 2010; Kovacs et al., 2014), central nervous system 
(CNS) diseases (Timbie et al., 2015). Following successful pre-clinical studies in a 
wide range of in vivo models including rodents, mammalians and non-human primates 
(NHP) (Marquet et al., 2011; Wu et al., 2016), FUS-based targeted drug delivery is 
currently evaluated in  clinical trials for the treatment of malignant brain tumors 
invasively (Carpentier et al., 2016) and Alzheimer’s disease (Lipsman et al., 2018).  
The delivery rate of drug molecules is limited by the FUS-induced BBB opening size 
(Choi et al., 2010; Marty et al., 2012). The latter is linked to and controllable by 
modulating the applied acoustic FUS pressure (Chen and Konofagou, 2014). 
Furthermore, the size dependent trans-BBB delivery rate of drug molecules is 
correlated with FUS-induced cavitation activity. Depending on the level of acoustic 
pressure, microbubble activity is described as stable cavitation (SC, low-pressure, low-
amplitude bubble oscillation) and inertial cavitation (IC, high-pressure, transient bubble 
collapse) (Neppiras, 1984; Miller et al., 1996).  
Passive cavitation detection (PCD) was proposed for real-time transcranial monitoring 
of the bubble behavior and resulting cavitation activity during FUS sonication 
(McDannold et al., 2006). Recently, PCD- based cavitation metrics have been utilized 
to predict the cavitation dose and BBB opening size (Tung et al., 2011), delivery 
efficiency of the molecules (Wu et al., 2016) and permeability and reversibility of BBB 
opening (Sun et al., 2015). It has been shown that FUS induced BBB opening does 
not necessarily require the occurrence of inertial cavitation. SC alone can provide a 
significant enhancement in the delivery efficiency of relatively large molecules (3-70 
kDa) (McDannold et al., 2006; Sun et al., 2017).  However, IC is needed to achieve 
delivery of very large molecules (500-2000 kDa) (Chen and Konofagou, 2014). 
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However, presence of IC increases the likelihood of vascular and neuronal damage as 
a result of violent bubble collapse (Aryal et al., 2014).  
Several previous publications attempted to achieve safe BBB opening by defining 
global values for the FUS pressures corresponding to thresholds for BBB opening, SC 
and IC. Tung et al reported pressures such as 0.30 MPa for BBB opening and 0.45 
MPa for IC in mice using a 1.5 MHz FUS transducer (Tung et al., 2010b). O’Reilly et 
al proposed an open-loop feed-back control to adjust the driving voltage of a FUS 
transducer operating at 551.5 kHz where the detection of ultra-harmonic emission from 
PCD signal is assumed to be the upper threshold for SC (O'Reilly and Hynynen, 2012). 
The pressure value was then set to a fraction of the determined threshold and the 
following sonication was performed at this fixed power level that was not further 
adjusted (open-loop). The pressure ranges for safe BBB opening from 0.18 MPa to 
0.40 MPa. Tsai et al proposed to use energy spectral density (ESD) as a spectrogram-
based metric and defined a BBB opening threshold on ESD as 5.5 dB for four different 
pressure levels using a 55 MHz FUS transducer (Tsai et al., 2016). However, they 
found significant variation on the resulting ESD values and further reported that the 
necessary exposure time to open the BBB depends on the individual animal conditions 
even with an identical exposure level.  
Modulating FUS pressure to compensate for inter-experimental discrepancies is still a 
major challenge. This mainly arises because designing such a real-time FUS power 
controller requires first to determine animal specific cavitation thresholds in-situ. Once 
the cavitation thresholds are defined, then the experiment can be executed in safe 
‘operation bands’. Obviously, determining global boundaries defining the limits of 
specific activity regimes independent from the physical (i.e. experimental setup, 
geometry, acoustic coupling) and physiological (i.e. inter-animal variation, 
physiological condition) dynamics of the experiment is not feasible. Additional 
difficulties in controlling cavitation activity arise from the varying concentration of the 
MBs over time after injection (Sun et al., 2017). The decreased MB lifetime (30-60s) of 
commonly used MBs by long-burst exposure of FUS prevents to reveal a robust 
characterization of the dynamic FUS-microbubble interaction (Pouliopoulos et al., 
2014; Pouliopoulos et al., 2016). Moreover, it has been reported that the targeted 
tissue type (i.e. gray and white matter) and vascular structure in the targeted volume 
may significantly influence the ultimate cavitation activity (Wu et al., 2016).  
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In this work, we developed and validated a closed-loop, real-time cavitation control 
framework to maximize BBB opening without causing macro tissue damage. To 
achieve this, we first analyzed the ‘long-term’ (5 min) temporal dynamics of the FUS-
MB interaction for a wide range of acoustic pressure levels. The ability of such a long-
term PCD monitoring was facilitated by the utilization of long-circulating MBs. The long-
term kinetic characterization enables to identify in-situ pressure dependent ‘band 
structures’ for different activity regimes.  However, this is a highly time consuming task 
because the long-term PCD monitoring has to be repeated for a wide range of FUS-
pressure levels. To overcome this, we tested a novel ‘pre-calibration’ method for fast 
determination of the desired operation band. For executing sonications reliably within 
this band, we developed an adaptive, closed-loop, feed-back power controller that 
dynamically updates FUS power between sonications. To assess the safety of the 
proposed methods, we quantified the severity of the tissue damage using a 
hemorrhage-scoring scheme. The controller setup subsequently was applied 
successfully in a preclinical study in mouse models of Glioblastoma Multiforme to 
deliver 80nm-sized liposomal MGMT inactivators (Signorell et al., 2018) to reverse 
chemoresistance against temozolomide (Papachristodoulou et al., 2018). 
Methods 
Animal Preparation 
All animal experimental procedures were reviewed and approved by the Cantonal 
Veterinary Office Zürich (Licence number 085/2014). A total of 35 wild-type adult 
female mice (strain: C57BL/6, age: 10 to 12 weeks, 25-28 g, Charles River, Freiburg, 
Germany) were used. Animals were anesthetized with 2-3% Isoflurane vaporized in a 
mixture of oxygen (flow rate: 1 L min-1 at 1.0 Bar, 21 °C).  To maintain the body 
temperature, animals were placed on a heating pad with a stable temperature of    ̴
38°C. The fur on the head was removed by using an electrical trimmer and a depilatory 
cream while the scalp and skull remained intact. A 27-gauge catheter was inserted into 
the tail vein for i.v. injections.   
 
Experimental Setup 
A schematic illustration of the setup for animal experiments is shown in figure.1. A MR-
compatible six channel annular array transducer (center frequency: 650 KHz, external 
diameter: 30 mm, focal depth: 30 mm, Imasonic, Besancon, France) was used for 
sonication. The multi-element design allowed electronic steering of the ultrasound 
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beam in depth. The transducer was mounted on an MR-compatible rodent FUS system 
that provided computer control for parametrization of the sonications and a motorized 
positioning system (Image Guided Therapy, Pessac, France) (Magnin R, 2015). The 
transducer was acoustically coupled to the rodent head with a custom-built truncated 
cone filled with deionized and degassed water and closed with a thin latex membrane. 
The cone was positioned above the target volume under MR-imaging guidance. A 
spherically focused, polyvinylidene fluoride (PVDF) hydrophone (center frequency: 2 ± 
0.2 MHz, Imasonic, Besancon, France) served as a passive cavitation detector for real-
time monitoring of the acoustic emissions arising from MB cavitation. The hydrophone 
was coaxially aligned with the FUS transducer. A custom-built MATLAB (Mathworks, 
MA, USA) program was used to control the sonications through the systems controller 
and to analyze the acquired PCD signals. The PCD signal was amplified by 20 dB (AH-
1100, Onda, CA, USA). The first (650 KHz) and second (1.3MHz) harmonic frequency 
components of the PCD signal was high-pass filtered (EF509, Thorlabs, NJ, USA) and 
digitized with 8 bit resolution using an USB driven oscilloscope (3204A, Pico 
Technology, Cambridgeshire, United Kingdom)  at a sampling rate of 50 MHz.   
BG8235 MBs, a non-commercial MB provided by Bracco Suisse SA, Geneva, 
Switzerland were used in this study. BG8235 is a phospholipid MB containing 
perfluorobutane with a mean-diameter of 3.24 μm and long circulating times similar to 
(Schneider et al., 2011). The MBs were freshly diluted to 3 mL with normal saline 
solution and injected through the tail vein (0.01 μL/g) by using an automated syringe 
pump (Harvard Apparatus, Boston, MA, USA). The infusion rate was 1 µL/s. The 
sonication was started thirty seconds after the onset of the microbubble infusion. At 
the beginning of the FUS exposure, a control sonication without MB injection was 
performed to obtain a baseline for cavitation monitoring for 30 s (Arvanitis et al., 2012).  
 
Acoustic Cavitation Emission Quantification 
As previously described (Tung et al., 2010b; Wu et al., 2014), acoustic emissions due 
to the MB-FUS interaction were quantified using inertial cavitation dose (ICD). 
Spectrograms were calculated for each acoustic emission signal acquired by the 
focused hydrophone. The harmonic (𝑛𝑛𝑛𝑛,𝑛𝑛 = 1,2, … ), sub-harmonic (𝑛𝑛/2) and ultra-
harmonic (𝑛𝑛𝑛𝑛/2, 𝑛𝑛 = 3,5, … ) frequencies were filtered by excluding ±150 kHz 
bandwidths to retain only the broadband response. The root-mean-square (rms) of the 
filtered spectral amplitude was computed to represent the ICD.  
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Figure 1. Schematic illustration of the experimental setup. A 650- kHz six channel MR-compatible 
focused ultrasound (FUS) transducer was used for sonication. It was confocally aligned with a 
spherically focused hydrophone for passive cavitation detection (PCD). The transducer and motorized 
2-axis mechanical positioning arm were driven by the system controller. A cone filled with degassed and 
deionized water filled provided acoustic coupling between the transducer and the rodent head.  
 
Long-Term ICD Monitoring 
To explore the dynamics of the ICD over time, ICD values were monitored for 5 min 
(“long term”) for a discrete range of acoustic pressure levels varying from 0.18 MPa up 
to 0.62 MPa with a step size of 0.03 MPa increments. For this purpose, seven mice 
were included in this part of the experiments. Figure.2.a illustrates the sonication 
scheme for long-term ICD monitoring. Following the injection of 50 μL of MBs, two 
consecutive pressure levels [0.25 MPa, 0.28 MPa] were repeatedly applied (pulse 
duration=10 ms, PRF=1 Hz) for 5 minutes duration and the ICD signal is monitored. A 
pre-pulse of 0.18 MPa was applied 5.6 ms before the onset of each sonication to obtain 
a reference baseline pressure level. Following the initial 5 min of recording, a fresh 
amount of 50 μL of MBs were injected and a second pair of acoustic pressure levels  
[0.31 MPa, 0.34 MPa] were repeatedly applied for 5 minutes duration and the ICD 
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signal is monitored. This procedure is repeated until the targeted acoustic pressure 
range is covered. Because two consecutive acoustic pressure levels were monitored 
following a fresh MB injection, the time that it takes to cover a range of acoustic 
pressures [𝑃𝑃1,𝑃𝑃2,…,𝑃𝑃𝑁𝑁] is 𝑁𝑁𝑁𝑁5/2 minutes. Third-degree polynomial curve fitting was 
applied to the acquired ICD data to obtain the long-term ICD kinetic curves.  
 
Pre-Calibration Method 
To apply in-situ pre-calibration in actual treatments, a sonication scheme was designed 
to scan the same range of pressure levels as in the long-term ICD monitoring 
experiments in much shorter amount of total time. It applies very short sonications 
(pulse duration=200 μs, PRF = 1 Hz) where 0.18 MPa pressure was emitted 5.6 ms 
before the onset of each pressure sequence as a low pressure baseline as in the long-
term monitoring experiments (figure.2.b). This allows to acquire all pre-calibration 
curves with only a single 50 μL microbubble solution injection. Following the MB 
injection, the targeted acoustic pressure range [𝑃𝑃1,𝑃𝑃𝑁𝑁]  is sonicated with an acoustic 
pulse series of [𝑃𝑃1,𝑃𝑃2,…,𝑃𝑃𝑁𝑁] in an increasing manner which takes 𝑁𝑁 seconds. To be able 
to acquire enough data to ensure a robust curve fitting, the experiment is repeated 
𝑅𝑅=10 times yielding a total duration of 𝑁𝑁𝑁𝑁𝑅𝑅 seconds. 
 
Closed-Loop Real-Time Feedback Power Control 
A closed-loop real-time feedback power controller was developed to ensure execution 
of the treatment within the prescribed operation band.  As before, the system relies on 
the real-time acquisition of the PCD signal, calculation of the instant ICD from the 
acoustic spectrogram of the acquired PCD signal, comparison of the instant ICD with 
the pre-determined boundaries of the operation band and determining the optimum 
FUS power to be applied for the next sonication. The controller decides for the optimum 
power level for the next time point by assessing the history in a certain time window 
(i.e. 10 s) instead of a single time point. The controller algorithm is described in detail 
in the appendix.  
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Figure 2. Sonication pulse sequences for long-term ICD monitoring and pre-calibration 
experiment. (a) Following 50 μL microbubble solution injection, FUS pulses at two different pressure 
levels are repeatedly applied (pulse duration=10 ms, PRF=1 Hz) for 5 min. A baseline pre-pulse of 0.18 
MPa is applied 5.6 ms before the onset of each pulse in the sequence. The sonication sequence is 
repeated following a fresh MB injection to obtain the ICD curves for different FUS pressure pairs. The 
total duration of long-term ICD monitoring experiment to cover [0.25 MPa-0.47 MPa] range with 8 FUS 
pressure levels is 20 min excluding the duration of MB injection. (b) For pre-calibration experiments, 
short acoustic pulses (pulse duration=200 μs, PRF = 1 Hz) were applied to scan the same range of 
pressure levels as in the long-term ICD monitoring experiments. The total duration of pre-calibration ICD 
monitoring experiment to cover [0.25 MPa-0.47 MPa] range with 8 FUS pressure levels is 80 s for R=10 
repetitions. 
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Sonication Experiments for Safety Analysis 
To assess the safety and quantify the induced damage of the different cavitation bands, 
7 mice were sonicated for each of the cavitation bands yielding a total of 28 animals. 
First, the pre-calibration experiment (0.25-0.62 MPa range, 1 min duration) was 
performed on each mouse to identify different cavitation regimes and to determine the 
boundaries of the operation band. Following the pre-calibration, 3-min sonication 
treatment was applied to each animal by using the feedback power control loop such 
that the instant ICD should fall into the desired cavitation zone. Furthermore, to validate 
the hypothesis that the short acoustic pulses applied during the pre-calibration 
experiment does not cause any considerable tissue damage, 7 mice were treated by 
only sonicating with the pre-calibration pulse trajectory as illustrated in Fig 2.b.  
 
Histological Examination and Statistical Analysis 
Whole brain histological analysis was performed on all brains. Animals were typically 
sacrificed 2 h after FUS exposure. The brain was transcardially perfused with 30 mL 
phosphate buffered saline (PBS) and 60 mL 4% paraformaldehyde. The post-fixation 
processing of the brain was then performed according to standard histological 
procedures. Serial horizontal cuts were performed every 250 μm starting from the 
surface of the brain and 10 sections were obtained for each brain. H&E staining was 
carried out in all sections to assess severity of hemorrhage, whilst BBB opening size 
was assessed on consecutive serial sections employing immunohistochemistry for 
albumin. 
A hemorrhage-scoring scheme was used to quantify the severity of erythrocyte 
extravasation in each H&E-stained section. Separate scoring systems ranging from 0 
to 3 were applied to assess the number of hemorrhages (0= no lesions;  1= < 5 
hemorrhagic foci; 2= 6-20; and 3= > 20), the size of the hemorrhages (0= no lesions;  
1= micro-hemorrhages, up to 30 μm in diameter; 2= small petechiae, up to 100 μm; 
and 3= large petechiae, often coalescing, composed of high numbers of erythrocytes, 
>100 μm in diameter) and the size of the affected area (0= no lesions;  1= the affected 
area is comprised within a 20 x power field, approx. 0.5 mm2; 2= the affected area is 
comprised within a 10 x power field, approx. 2 mm2, and 3 = the affected area is 
comprised within a 4x or lower power field (approx. equal or more than 12 mm2). A 
final cumulative score for hemorrhage, ranging from (0) to (4), was obtained by 
summing the partial scores and was defined according to the following criteria: (1) Few, 
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focal small hemorrhages, (2) Few, multiple, moderately-sized hemorrhages or 
numerous multiple small hemorrhages, (3) Numerous, moderately sized or large, often 
coalescing hemorrhages, (4) Larger hemorrhages, often associated with significant 
vasogenic edema, characterized by vacuolation of the neuropil. Average final scoring 
for each animal was calculated summing the final scores for each section, excluding 
the first and the last. Figure.3 provides a graphical illustration of the proposed 
hemorrhage-scoring scheme. To determine whether the resulting hemorrhage scores 
were statistically different between the sonications operated at different cavitation 
bands, a one way ANOVA with Tukey post hoc analysis were deployed for pairwise 
comparisons where p<0.01 was considered to denote significant differences. The 
immunohistochemical staining for the albumin antigen served for the assessment of 
blood-brain barrier integrity (Saunders et al., 2015). Immunohistochemistry was 
applied to four brain sections in each mouse, consecutive to those obtained for the 
H&E staining and taken at a distance of 1250 to 2000 µm from the dorsal surface of 
the brain. Briefly, sections were deparaffinized in xylene and rehydrated through 
graded ethanol. For antigen retrieval, sections were incubated in citrate buffer (pH 6.0) 
for 20 min at 98 °C. This was followed by incubation with a goat polyclonal albumin 
antibody (Bethyl A80-129A, 1:600 dilution in Dako antibody diluent, Dako-Agilent 
Technologies, Denmark) overnight at 4 °C. Afterwards, the slides were incubated for 
30 min with a horseradish peroxidase (HRP)-labeled polymer, conjugated to a 
secondary anti-goat antibody (P0160, Dako-Agilent Technologies). The reaction was 
visualized using 3,3’-diaminobenzidine (DAB) as chromogen, followed by light 
counterstain with hematoxylin. The immunohistochemical staining was performed 
using an Autostainer (Dako Autostainer Universal Staining System Model LV-1, Dako-
Agilent Technologies). 
All immunolabeled slides were scanned using a digital slide scanner (NanoZoomer-XR 
C12000; Hamamatsu, Japan), and the area of albumin-positive regions was calculated 
in the digital slides using the Visiopharm Integrator System (VIS, version 4.5.1.324, 
Visiopharm, Hørsholm, Denmark). Briefly, a threshold classification allowed 
recognition of positive (brown) neuroparenchyma and negative regions. 
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Results 
ICD kinetic curves and cavitation bands 
A typical example for the kinetic curves obtained from Long-term ICD monitoring of a 
representative mouse is shown in Figure.4.a. It reveals a band structure formed by 
sudden jumps in ICD at certain pressure levels (0.37 MPa and 0.50 MPa) and related 
increase of the standard deviation. Also, there is a decrease in ICD over time 
particularly for the curves above the first jump point. We hypothesize: i) There exists 
an acoustic pressure dependent band structure of the long-term ICD curves with band-
specific properties corresponding to different activity regimes. Different activitiy bands 
were identified based on the significant change in the magnitude of ICD curves such 
as steady oscillation band (SO), transition zone (TR), inertial cavitation band (IC) and 
high-pressure zone (HP). The bandwidth of each zone was defined by the standard 
deviation of the ICD data.  ii) Although the driving acoustic pressure level is constant, 
ICD varies in time with a band-dependent standard deviation reflecting an intra-animal 
variation illustrated in Figure.4.c corresponding to the standard deviation of the ICD 
signals plotted in Figure 4.a. iii) The ICD levels defining the boundaries of different 
activity bands varies between individual animals revealing an inter-animal variation 
(Figure.4.b). 
 
 
 
 
 
 
 
 
Figure 3. Hemorrhage scoring. The final hemorrhage-scoring scheme to quantify the severity of 
erythrocyte extravasation includes a score from 1-4 considering the number of hemorrhages, the size 
of hemorrhages, the size of affected area, the neuropil rarefaction. (1) Few, focal small hemorrhages 
(2) Few, multiple, moderately-sized hemorrhages or numerous multiple small hemorrhages (3) 
Numerous, moderately sized or large, often coalescing hemorrhage (4) Larger hemorrhages, often 
associated with significant vasogenic edema. 
 
 
 
OR + 
EDEMA 
(1) (2) (3) (4) 
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Pre-calibration experiments 
Figure.5.a illustrates the long-term ICD kinetic curves of a specific animal and the 
identified activitiy zones. Figure.5.b shows the ICD curves and activitiy bands obtained 
from the pre-calibration experiment for the same animal. The qualitative comparison of 
the limits of the activitiy bands obtained from long-term monitoring and pre-calibration 
method implies that there is a good reproducibility between the two methods. For 
quantitative validation of the proposed pre-calibration method, the ICD values obtained 
from pre-calibration method vs long-term monitoring experiments were compared by 
calculating the correlation on seven animals that underwent in both experiments 
(Figure.5.c). While there is high correlation in the resulting ICD values obtained (𝑅𝑅2 = 0.81), the pre-calibration method takes much shorter time (N=8 pressures, R=10 
repetitions, 8x10=80 s) relative to the long-term monitoring experiments (N=8 pressure 
levels, 8x5/2=20 min) and requires 4 fold less MB solution injection.  
 
Closed-loop real-time feedback power control 
Figure.6.a provides an overall summary of the developed closed-loop feedback power 
controller. The FUS pressure is initialized according to the desired operation band and 
increased with a discrete step-size of 1% of the maximum possible power 
corresponding to 0.03MPa acoustic pressure level (pulse duration 10 ms, PRF = 1 Hz). 
Figure.6.b illustrates how the applied FUS power is adaptively modulated to keep the 
instant ICD within the limits of the operation band. The control algorithm successfully 
assures a stable oscillation of the ICD within the desired operation band to induce the 
targeted cavitation activity. The physiological dissolution kinetics of the MBs led to an 
increasing pattern of the applied FUS exposure level to maintain the similar level of 
cavitation.  
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Figure 4. Long-term monitoring of ICD kinetic curves. (a) The long-term ICD kinetic curves were 
obtained from a representative mouse by executing the sonication pulse sequence illustrated in Figure 
2. The long term monitoring duration to obtain all the ICD curves in the graph is 25 minutes (N=10 
pressure levels) and the practical duration by considering the time for the preparation and injection of 
fresh MBs between sonications is approximately 25-30 min. There exists an acoustic pressure 
dependent band structure of the long-term ICD curves with band-specific properties corresponding to 
different activity regimes such as steady oscillation (SO) band, transition (TR) zone, inertial cavitation 
(IC) band and high-pressure (HP) zone. (b) The ICD levels defining the boundaries of specific activitiy 
bands vary between individual animals (5 min monitoring of each mouse from mouse 1 to mouse 7) 
revealing a setup-specific variations. (c) Although the driving acoustic pressure level is constant, ICD 
varies in time with a band-dependent standard deviation (standard deviation of the ICD curves if Fig.4.a.) 
reflecting characteristics of the respective activity mode.  
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Figure 5. Pre-calibration method vs long-term ICD monitoring. (a) The long-term ICD kinetic curves 
of an individual animal. The total duration to obtain all the ICD curves in the graph is 20 min (N=8 
pressure levels). Different cavitation activity regimes and zones such as steady oscillation (SO) band, 
transition (TR) zone, inertial cavitation (IC) band and high-pressure (HP) zone were identified based on 
the ICD kinetic curves (b) ICD curves and cavitation bands and zones obtained from the pre-calibration 
experiment for the same animal. The qualitative comparison of the limits of the transcranial cavitation 
bands obtained from long-term monitoring and pre-calibration method implies that there is a good 
reproducibility of the individual cavitation bands (c) Quantitative comparison of the ICD values for seven 
animals obtained from pre-calibration method and long-term ICD monitoring.  
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Figure 6. Closed-loop feedback power control. (a) Algorithmic scheme for the closed-loop feedback 
power control (b) The FUS power is dynamically updated to keep the instant ICD for the next time point 
should stay within the limits of the operation band. 
 
BBB opening and safety 
Following the successful execution of the FUS sonication such that the desired level 
of cavitation activity was induced, the severity of resulting tissue damage was 
assessed using histological examinations. The relation between the scale of 
erythrocyte extravasation measured by the proposed hemorrhage scoring scheme and 
the BBB opening volume obtained from the albumin immunohistochemistry for different 
exposure zones was monitored (Figure 7). Figure.7.a shows a representative 
photomicrograph of H&E-stained brain sections. An enhanced level of erythrocyte 
extravasation and neuroparenchymal hemorrhages with increasing cavitation activity 
was observed. Figure.7.b illustrates the BBB opening determined using albumin 
immunolabeling. There is a corresponding enlargement in the BBB opening size as a 
result of the increased cavitation activity. Figure.7.c demonstrates the severity of the 
tissue damage quantified using the proposed hemorrhage scoring scheme for different 
cavitation bands as a histogram plot (note that 7 animals were sonicated at each 
cavitation band). While average hemorrhage score is below (1) for pre-calibration 
experiments and SO band, it substantially increases with the increasing cavitation 
level. Correspondingly, there is a significant enlargement in the size of BBB opening 
with the enhanced cavitation activity provided by the histogram in Figure 7.d. The 
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statistically significant differences (p<0.01) for the hemorrhages scores and BBB 
opening size for different cavitation bands were indicated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Activitiy band dependent safety characteristics and BBB opening size (a) Representative 
photomicrograph of H&E-stained brain sections exhibiting enhanced level of erythrocyte extravasation 
and neuroparenchymal hemorrhages with increasing cavitation activity (* denotes p<0.01) (b) 
enlargement in the BBB opening size with increasing cavitation activity determined using Albumin 
immunolabeling (* denotes p<0.01). 
 
Discussion 
 
In this study, we demonstrated a novel method to determine the in-situ, animal specific 
relationship between the acoustic pressure levels and induced cavitation activity to 
minimize the inter- and intra-animal effects during FUS therapy by using a specific type 
of long-circulating MBs (Schneider et al., 2011) . Note that the boundaries of the 
specific activity regimes are highly dependent to the physical (i.e. experimental setup, 
geometry, acoustic coupling) and physiological (i.e. inter-animal variation, 
physiological condition) dynamics of the experiment. The major advantage of the 
proposed method is that it enables to characterize different level of activities with 
corresponding ‘activity bands’ for an individual animal and for the given experimental 
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conditions in a short amount of time and without causing any macro tissue damage. 
Determining the boundaries of the cavitation doses for different cavitation regimes 
allows to run the FUS treatment at a selected operation band to suppress the 
occurrence of IC with the ultimate goal of maximizing the BBB opening while avoiding 
macro tissue damage. Furthermore, in order to stably execute the FUS sonication in 
the pre-determined operation band and account for the variations in bubble kinetics 
and physiological conditions of the animal, we developed and validated a closed-loop, 
real-time transcranial cavitation control framework. With the controller, we were able 
to optimize the FUS pressure instantly and modulate it in real-time to maintain the 
targeted cavitation level for the time course of the treatment while improving safety 
control.   
In previous studies, the correlation between spectral components of the MB emission 
and FUS induced BBB opening have been reported in different animal models (Wu et 
al., 2016; Vykhodtseva et al., 1995). It has been shown that harmonic, sub-harmonic, 
ultra-harmonic activity and broad-band noise can serve as indicators to measure the 
cavitation level and therefore to monitor BBB opening (McDannold et al., 2006; Tung 
et al., 2010a). In the present work, the broadband response as detected by PCD was 
quantified using the ICD. This was based on previous approaches that reported 
significant correlation between the broadband noise and inertial cavitation (Tung et al., 
2010b). Note that relatively poor vertical resolution of the digitizer used in this study (8 
bits) the limited frequency bandwidth of the PCD transducer could affect the ICD 
quantification. In this respect, filtering the 1st and 2nd harmonic of the PCD signal could 
help in decreasing the dynamic range of the signal. However, windowing reduces the 
energy of the signal and also blur the energy at specific frequencies over nearby 
frequencies (Haworth et al., 2017). Compensating for such a convoluted 
representation can be difficult and encoding the signal with a high resolution hardware 
is preferable. 
 
The results obtained by using long circulating MBs lead to understanding the long-term 
temporal dynamics of the cavitation activity measured by ICD. The sudden jump in the 
ICD curves above a certain pressure level is actually in agreement with the results 
reported by (Tung et al., 2010b) where it was found that the ICD at 0.45 MPa and 0.60 
MPa was statistically higher than that of 0.30 and 0.15 MPa indicating a threshold for 
inertial cavitation and BBB opening. The ICD curves below the first jump pressure 
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represents a SO activity or composes a ‘steady oscillation regime’ while those above 
the jump pressure represent IC or create an ‘inertial cavitation regime’ following a 
‘transition zone’. Further increase in the acoustic pressure causes a second jump that 
could be defined as a separate ‘high pressure zone’. The increased standard deviation 
in higher operation bands might be linked to both physical and physiological sources. 
On the physical side, the mechanistic response of the oscillating MBs under an 
acoustic field could be more unsteady and variable at high-pressure levels relative to 
low-pressure levels. This might be reflected in the ICD curves at ‘inertial cavitation 
regime’ as an increased standard deviation in time. Furthermore, the physiological 
condition of the sonicated animal might also significantly change during the course of 
the experiment as a response to increased applied acoustic pressure to the brain. This 
might also contribute to the increased standard deviation of the ICD values at higher-
pressure levels. Finally, the decreasing tendency of the ICD values over time is 
probably due to the decreased bubble quality and concentration because of distortion 
and collapse under the acoustic field and blood circulation.  
The outcomes of the long term ICD monitoring regarding the inter-animal variations 
imply that it is hard to define a global ICD threshold for a certain cavitation regime that 
is valid for all animals and independent from all deployed experimental geometry and 
setup and its coupling between the animal. In principle, long-term ICD kinetic curves 
of a specific animal may serve as a gold standard to determine the boundaries of the 
cavitation regimes to run the experiment within a specific operation band depending 
on the demands of the experiment such as occurrence and size of the BBB opening. 
However, there are some major challenges in such an approach: First, the full long-
term monitoring of the ICD kinetics may take around 20-30 min depending on the range 
of scanned pressure levels that is certainly not feasible in experiments. Second, it is 
required to inject a certain amount of MB suspension to obtain the long-term ICD kinetic 
curves that limits the amount of applicable liquid for the rest of the experiments. Third, 
monitoring the ICD curves particularly for higher pressure levels are subject to safety 
concerns.  Therefore, the proposed pre-calibration method substantially speeds-up the 
process to safely determine animal-specific transcranial cavitation thresholds for the 
targeted cavitation regime with minimum possible liquid injection. This finding is 
promising because it suggests physically and physiologically independent cavitation 
thresholds.  
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A further concern is subject to safety and the proposed pre-calibration method relies 
on the assumption that short FUS pulses (200 μs duration) in the prescribed pressure 
range do not cause any macro tissue damage. To validate the proposed approach for 
the safety concerns, a separate set of experiment was designed and performed on 
seven mice where the animals went through pre-calibration experiment only. The 
resulting average hemorrhage scoring (0.36 ± 0.47) implies that pre-calibration method 
does not cause any considerable red-blood cell extravasation and is fully safe for 
executing before the actual sonication treatment to determine the in-situ, animal 
specific transcranial cavitation limits.   
To stably run the experiment within the determined operation band, a closed-loop 
adaptive feedback power controller was developed. The major challenge for the control 
problem is the time-varying MB kinetics and animal physiology. In the pilot experiments 
for deciding the optimum FUS pressure level that will be applied at the next time point, 
it has been observed that taking into account a certain history instead of using the 
recent ICD value increases the stabilization of ICD controlling challenge. In order to 
improve the control over the instant cavitation level, the controller algorithm allows to 
select the size of the window in which the previous ICD values are included. Our 
findings indicate that assessing a longer ICD history more than 10 s did not created a 
considerable change in the next FUS pressure level. 
The histological findings in this work are consistent with the existing literature that 
explored the correlation between inertial cavitation and erythrocyte extravasation 
(Hwang et al., 2006; Samuel et al., 2009; Tung et al., 2010b; Tsai et al., 2016). It has 
been previously reported that excessive FUS exposure may result varying severity of 
erythrocyte extravasation which might be minor without causing any hazard or large 
scale inducing significant vascular and neuronal damage (Hynynen et al., 2005; Liu et 
al., 2008). In general, it is well-accepted that strong IC could increase the likelihood of 
the damage and enhances the post-safety concerns. In this study, we additionally 
explored the BBB opening size achieved at different activity bands and corresponding 
safety characteristics of each band quantitatively measured by a proposed 
hemorrhage scoring scheme. The high correlation (𝑟𝑟2 = 0.84) between the band 
dependent BBB opening size and the hemorrhage scores indicate that there is a 
tradeoff between efficiency and safety. Operating the experiment at SO band or in the 
transition zone results a relatively lower average hemorrhage score suggesting a safe 
sonication without any considerable damage. While the BBB opening size becomes 
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larger for the IC band and high-pressure zone as expected, the resulting hemorrhage 
scores are not acceptable for the operation.  
Contrast enhanced magnetic resonance imaging (MRI) or 𝑇𝑇2∗ weighted imaging could 
alternatively be used for assessing the size of BBB opening and damage (Hynynen et 
al., 2001; McDannold et al., 2012; Marquet et al., 2011). However, MRI-based safety 
assessment has to be performed after the sonication and the long pulse sequence 
duration needed to acquire the image makes it highly challenging to integrate with a 
closed-loop feedback control framework. Moreover, vascular damage could take much 
longer (tens of seconds) to appear in MRI that further limits its usage as a real time 
control system.  
While the described closed-loop cavitation control methods have been applied 
successfully in a preclinical study in mouse models of Glioblastoma Multiforme to 
deliver 80nm-sized liposomal MGMT inactivators (Signorell et al., 2018) to reverse 
chemoresistance against temozolomide (Papachristodoulou et al., 2018), several 
factors could improve the presented work. First, to extend the proposed methods for 
potential clinical use, the effect of many different factors has to be investigated mainly 
including the spatial attenuation due to the skull (Tung et al., 2010a) where the 
increased distance to the focal point will decrease the detection sensitivity of the 
cavitation signal. Second, it has been reported that the heterogeneity of the brain 
anatomy and vasculature (presence of large cerebral vessels, gray and white matter) 
significantly affects the cavitation activity (Wu et al., 2016) mainly because the MBs 
circulating in large vessels exhibits a different response to FUS exposure (Sassaroli 
and Hynynen, 2006, 2007). Therefore, it would also be beneficial to study the effect of 
the tissue type on the strength of the cavitation signal and the ultimate controller 
behavior for future studies. The clinical translation of the presented method certainly 
needs scaling to larger animal models because the presence of the skull is a major 
challenge for the application of the FUS-mediated BBB opening. It has been recently 
demonstrated a feed-back control system for ultrasound mediated BBB disruption with 
high-field MRI guidance in monkeys (Kamimura et al., 2018). The proposed pre-
calibration method in this work could be integrated in such a framework to improve the 
efficacy and safety of the treatments by minimizing the inter- and intra-animal variability 
and the effects of in-situ experimental conditions.  Moreover, the infusion rate of the 
MBs can be optimized such that it compensates the decreasing tendency of the bubble 
kinetics and provides a cavitation signal in steady-state for the constant pressure 
Page 21 of 27 AUTHOR SUBMITTED MANUSCRIPT - PMB-107793.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
a
us
cri
pt
22 
 
levels. To achieve this, future work could consider the infusion rate as an additional 
constraint in the optimization problem of the control algorithm. Finally, in this study, 
passive cavitation detection was performed using a single channel receiver that 
collects all the emission signal from the active field. Passive cavitation imaging to 
achieve a spatially resolved cavitation activity map (Arvanitis et al., 2013; O'Reilly et 
al., 2014; Gateau et al., 2011) or binary cavitation localization using a single PCD 
(Maimbourg et al., 2018)  may be integrated to the proposed controller framework to 
improve its performance.   
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Appendix 
By assuming a constant scalar relation between the applied FUS power (𝑝𝑝) and the 
resulting ICD level (𝐼𝐼𝐼𝐼𝐼𝐼) in a simplified case such that 
𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡 = 𝑐𝑐.𝑝𝑝𝑡𝑡 
𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡−1 = 𝑐𝑐.𝑝𝑝𝑡𝑡−1 
… 
𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡−𝑘𝑘 = 𝑐𝑐.𝑝𝑝𝑡𝑡−𝑘𝑘 
where 𝑡𝑡 is time and 𝑘𝑘 is the number of samples that have an effect on the ICD level for (𝑘𝑘 + 1) th sample. In other words 𝑘𝑘 is the window size that is assessed as the history 
to determine for the next time point’s FUS power. If the ideal ICD level to operate the 
treatment is 𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖𝑖𝑖 (i.e. mean of the operation band), than the cost function is defined 
as   
 min
𝑐𝑐
�(𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖𝑖𝑖 − 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡−𝑖𝑖)2𝑘𝑘
𝑖𝑖=0
 
 
                             [1] 
 
 
If the Eq.1 is solved for 𝑐𝑐,  
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 𝜕𝜕
𝜕𝜕𝑐𝑐
 �min
𝑐𝑐
�(𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖𝑖𝑖 − 𝑐𝑐.𝑝𝑝𝑡𝑡−𝑖𝑖)2𝑘𝑘
𝑖𝑖=0
� = 0 
 
 [2] 
 
 
𝑐𝑐 = ∑ 𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖𝑖𝑖 .𝑝𝑝𝑡𝑡−𝑖𝑖𝑘𝑘𝑖𝑖=0
∑ 𝑝𝑝𝑡𝑡−𝑖𝑖
2𝑘𝑘
𝑖𝑖=0
 
  
                             [3] 
Then the power level that has to be applied for the time point (𝑡𝑡 + 1) is given as 
 
 
𝑝𝑝𝑡𝑡+1 = 𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖𝑖𝑖 𝑐𝑐  
 
                            [4] 
 
By considering a more realistic case where the applied FUS power (𝑝𝑝) does not only 
has a constant scalar relation with ICD level (𝐼𝐼𝐼𝐼𝐼𝐼) but a linear relationship such that 
 
 
 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡 =  𝑐𝑐1.𝑝𝑝𝑡𝑡 + 𝑐𝑐2.𝑝𝑝𝑡𝑡−1 + ⋯+ 𝑐𝑐𝑘𝑘.𝑝𝑝𝑡𝑡−(𝑘𝑘−1) 
 
        [5] 
 
Then 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡+1 will be  
 
 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡+1 =  𝑐𝑐1.𝑝𝑝𝑡𝑡+1 + 𝑐𝑐2.𝑝𝑝𝑡𝑡 + ⋯+ 𝑐𝑐𝑘𝑘.𝑝𝑝(𝑡𝑡−𝑘𝑘) 
 
    [6] 
 
Let us define 𝐴𝐴 as 
 𝐴𝐴 = 𝑐𝑐2.𝑝𝑝𝑡𝑡 + ⋯+ 𝑐𝑐𝑘𝑘.𝑝𝑝(𝑡𝑡−𝑘𝑘) 
 
                            [7] 
Then, 
 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡+1 = 𝑐𝑐1.𝑝𝑝𝑡𝑡+1 + 𝐴𝐴 
 
                            [8] 
 
 
𝑝𝑝𝑡𝑡+1 = 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡+1 − 𝐴𝐴𝑐𝑐1  
 
                            [9] 
 
The equations can be written in matrix form such that X is a 𝑘𝑘x𝑘𝑘 matrix (2𝑘𝑘 window 
size) and ICD is 𝑘𝑘x1 vector such as 
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𝐗𝐗 = � 𝑝𝑝𝑡𝑡    𝑝𝑝𝑡𝑡−1 ⋯ 𝑝𝑝𝑡𝑡−𝑘𝑘⋮ ⋱ ⋮
𝑝𝑝𝑡𝑡−𝑘𝑘  𝑝𝑝𝑡𝑡−𝑘𝑘−1 ⋯ 𝑝𝑝𝑡𝑡−2𝑘𝑘� 
 
                  [10] 
 
 ICD = [𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡  𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡−1 … 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡−𝑘𝑘]𝑇𝑇 
 
                 [11] 
 
 𝐰𝐰 = [𝑐𝑐1, 𝑐𝑐2, … , 𝑐𝑐𝑘𝑘] 
 
                            [12] 
Then, the coefficients are calculated with the following closed form solution such as 
 𝐰𝐰 = (𝐗𝐗𝑇𝑇𝐗𝐗)−𝟏𝟏𝐗𝐗𝑻𝑻𝐈𝐈𝐈𝐈𝐈𝐈 
 
                          [13] 
 
After computing the coefficients 𝐰𝐰, one can calculate 𝐴𝐴 and substitute in Eq.9 to find 
out the  𝑝𝑝𝑡𝑡+1. 
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